These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19484724)

  • 1. The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[(18)F]fluoro-A-85380.
    Ellis JR; Nathan PJ; Villemagne VL; Mulligan RS; Ellis KA; Tochon-Danguy HJ; Chan JG; O'keefe GJ; Bradley J; Savage G; Rowe CC
    Synapse; 2009 Sep; 63(9):752-63. PubMed ID: 19484724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.
    Ellis JR; Villemagne VL; Nathan PJ; Mulligan RS; Gong SJ; Chan JG; Sachinidis J; O'Keefe GJ; Pathmaraj K; Wesnes KA; Savage G; Rowe CC
    Neurobiol Learn Mem; 2008 Sep; 90(2):404-12. PubMed ID: 18620875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET.
    Ellis JR; Nathan PJ; Villemagne VL; Mulligan RS; Saunder T; Young K; Smith CL; Welch J; Woodward M; Wesnes KA; Savage G; Rowe CC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):79-91. PubMed ID: 18949462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.
    Meyer PM; Strecker K; Kendziorra K; Becker G; Hesse S; Woelpl D; Hensel A; Patt M; Sorger D; Wegner F; Lobsien D; Barthel H; Brust P; Gertz HJ; Sabri O; Schwarz J
    Arch Gen Psychiatry; 2009 Aug; 66(8):866-77. PubMed ID: 19652126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.
    Mitkovski S; Villemagne VL; Novakovic KE; O'Keefe G; Tochon-Danguy H; Mulligan RS; Dickinson KL; Saunder T; Gregoire MC; Bottlaender M; Dolle F; Rowe CC
    Nucl Med Biol; 2005 Aug; 32(6):585-91. PubMed ID: 16026705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.
    Gallezot JD; Bottlaender M; Grégoire MC; Roumenov D; Deverre JR; Coulon C; Ottaviani M; Dollé F; Syrota A; Valette H
    J Nucl Med; 2005 Feb; 46(2):240-7. PubMed ID: 15695782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment.
    Mitsis EM; Reech KM; Bois F; Tamagnan GD; Macavoy MG; Seibyl JP; Staley JK; van Dyck CH
    J Nucl Med; 2009 Sep; 50(9):1455-63. PubMed ID: 19690024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.
    Kendziorra K; Wolf H; Meyer PM; Barthel H; Hesse S; Becker GA; Luthardt J; Schildan A; Patt M; Sorger D; Seese A; Gertz HJ; Sabri O
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):515-25. PubMed ID: 21069319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
    Le Foll B; Chefer SI; Kimes AS; Shumway D; Goldberg SR; Stein EA; Mukhin AG
    J Nucl Med; 2007 Sep; 48(9):1492-500. PubMed ID: 17704243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study.
    Picard F; Bruel D; Servent D; Saba W; Fruchart-Gaillard C; Schöllhorn-Peyronneau MA; Roumenov D; Brodtkorb E; Zuberi S; Gambardella A; Steinborn B; Hufnagel A; Valette H; Bottlaender M
    Brain; 2006 Aug; 129(Pt 8):2047-60. PubMed ID: 16815873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT.
    Mitsis EM; Cosgrove KP; Staley JK; Bois F; Frohlich EB; Tamagnan GD; Estok KM; Seibyl JP; van Dyck CH
    Neurobiol Aging; 2009 Sep; 30(9):1490-7. PubMed ID: 18242781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors.
    Horti AG; Kuwabara H; Holt DP; Dannals RF; Wong DF
    J Labelled Comp Radiopharm; 2013; 56(3-4):159-66. PubMed ID: 24285321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic α4β2 acetylcholine receptors and cognitive function in Parkinson's disease.
    Lorenz R; Samnick S; Dillmann U; Schiller M; Ong MF; Faßbender K; Buck A; Spiegel J
    Acta Neurol Scand; 2014 Sep; 130(3):164-71. PubMed ID: 24762290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-methyl-2-(S)-pyrrolidinylmethoxy)pyridine and its analogues as PET radioligands for imaging nicotinic acetylcholine receptors.
    Brown L; Chefer S; Pavlova O; Vaupel DB; Koren AO; Kimes AS; Horti AG; Mukhin AG
    J Neurochem; 2004 Nov; 91(3):600-12. PubMed ID: 15485491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
    Kas A; Bottlaender M; Gallezot JD; Vidailhet M; Villafane G; Grégoire MC; Coulon C; Valette H; Dollé F; Ribeiro MJ; Hantraye P; Remy P
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1601-8. PubMed ID: 19491921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.
    Kadir A; Almkvist O; Wall A; Långström B; Nordberg A
    Psychopharmacology (Berl); 2006 Nov; 188(4):509-20. PubMed ID: 16832659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography experience with 2-[¹⁸F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[¹⁸F]FA) in the living human brain of smokers with paranoid schizophrenia.
    Brašić JR; Cascella N; Kumar A; Zhou Y; Hilton J; Raymont V; Crabb A; Guevara MR; Horti AG; Wong DF
    Synapse; 2012 Apr; 66(4):352-68. PubMed ID: 22169936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain.
    Brody AL; Mandelkern MA; London ED; Khan A; Kozman D; Costello MR; Vellios EE; Archie MM; Bascom R; Mukhin AG
    Arch Gen Psychiatry; 2011 Sep; 68(9):953-60. PubMed ID: 21536968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.